<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>We administered antithymocyte globulin to a 52-year-old man with cutaneous <z:mp ids='MP_0000612'>sclerosis</z:mp> (<z:hpo ids='HP_0100324'>scleroderma</z:hpo>) and severe <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> for treatment of the aplastic lesion </plain></SENT>
<SENT sid="1" pm="."><plain>The use of this therapy resulted not only in marrow recovery but also in resolution of the <z:mp ids='MP_0000612'>sclerosis</z:mp> </plain></SENT>
<SENT sid="2" pm="."><plain>This observation indicates that T lymphocytes, their products, or both, are important factors in the pathogenesis of cutaneous <z:mp ids='MP_0000612'>sclerosis</z:mp> </plain></SENT>
<SENT sid="3" pm="."><plain>Furthermore, the success of this treatment could play a role in future investigations involving the treatment of <z:hpo ids='HP_0100324'>scleroderma</z:hpo> and <z:hpo ids='HP_0100324'>scleroderma</z:hpo>-like conditions </plain></SENT>
</text></document>